arrow
W

Wataru Fukuokaya

the jikei university hospital
H指数:17
被引数:1,091

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Clinical Impact of Gleason Pattern 5 on Doublet Versus Triplet Therapy in Metastatic Hormone-Sensitive Prostate Cancer

转移性激素敏感性前列腺癌中 Gleason 图案 5 对双药与三药疗法临床影响的比较

2026-09-290
OAAI
Association of time to upfront treatment initiation with outcomes in metastatic hormone-sensitive prostate cancer: a 4-month landmark analysis

转移性激素敏感前列腺癌中,启动一线治疗的时间与预后的关系:一项4个月标志点分析

2026-09-250
PRE
Baseline Disease Characteristics and Platinum Sensitivity as Predictors of Outcomes in Sequential Therapy with Platinum-Based Chemotherapy, Avelumab Maintenance, and Enfortumab Vedotin in Advanced Urothelial Carcinoma (ARON-2EV Study)

基线疾病特征和铂类药物敏感性作为顺铂为基础化疗、阿维鲁姆单抗维持治疗和恩沃利单抗维多汀序贯疗法在晚期尿路上皮癌中的预后预测因素(ARON-2EV研究)

2026-07-290
PRE
IS THE DIGITAL RECTAL EXAM (DRE) STILL RELEVANT IN THE ERA OF MRI IMAGING? RESULTS OF AN INTERNATIONAL MULTI-INSTITUTIONAL STUDY

数字直肠检查(DRE)在MRI成像时代是否仍然相关?国际多机构研究的结果

2026-05-010
PRE
Assessment of Circulating Neuroendocrine Tumor Markers at Prostate Cancer Diagnosis: An Investigation of Prostate Cancer With Neuroendocrine Features

前列腺癌诊断时循环神经内分泌肿瘤标志物的评估:一项针对具有神经内分泌特征的前列腺癌的研究

2026-04-170
PRE
Comprehensive analysis of oncological outcomes of radical cystectomy for non-muscle invasive bladder cancer

根治性膀胱切除术治疗非肌层浸润性膀胱癌的肿瘤学结果综合分析

2026-04-050
OAAI
Real-world comparison of enzalutamide and apalutamide in metastatic hormone-sensitive prostate cancer: a multi-institutional propensity score-matched analysis

真实世界研究中恩扎卢替尼与阿帕卢替尼在转移性激素敏感性前列腺癌中的比较:一项多中心倾向性评分匹配分析

2026-03-010
PRE
Impact of Proton Pump Inhibitor Use on the Efficacy of IO-IO Versus IO-TKI Therapy in Metastatic Renal Cell Carcinoma

质子泵抑制剂使用对转移性肾细胞癌中IO-IO与IO-TKI疗法疗效的影响

2026-03-010
PRE
A real-world comparison of nivolumab plus cabozantinib and pembrolizumab plus lenvatinib focusing on safety outcomes in metastatic renal cell carcinoma: results from the JK-FOOT consortium

一项针对真实世界中nivolumab联合cabozantinib与pembrolizumab联合lenvatinib在转移性肾细胞癌中的安全性结局比较研究:JK-FOOT联盟的结果

2026-02-250
OAAI
Clinical profiles and predictors of symptomatic skeletal events in patients with metastatic castration-resistant prostate cancer receiving denosumab

转移性去势抵抗性前列腺癌患者中症状性骨骼事件的临床特征和预测因子,在接受地诺单抗治疗时。

2025-12-090
PRE
Real-World Comparison of Survival Outcomes Between Radical Cystectomy and Intravesical Bacillus Calmette-Guérin (BCG) Therapy in BCG-Naïve or -Unresponsive Non-Muscle-Invasive Bladder Cancer

真实世界中根治性膀胱切除术与经尿道巴氏卡介苗(BCG)疗法在BCG初治或难治性非肌层浸润性膀胱癌患者生存结局的比较

2025-12-011
PRE
Apalutamide-induced rash and relative dose intensity in metastatic castration-sensitive prostate cancer: a multicenter Japanese cohort study

阿帕卢他胺诱导的皮疹与相对剂量强度在转移性去势敏感前列腺癌中的关系:一项多中心日本队列研究

2025-11-300
PRE
Time to metastasis as a prognostic factor in metastatic urothelial carcinoma: results from the ARON-2 study

转移时间作为转移性尿路上皮癌的预后因素:ARON-2研究的结果

2025-11-210
PRE
The Impact of Early Modification of Upfront Androgen Receptor Signaling Inhibitors on Survival Outcomes in Metastatic Hormone-Sensitive Prostate Cancer

早期调整一线雄激素受体信号抑制剂对转移性激素敏感性前列腺癌生存结局的影响

2025-11-060
PRE
Safety profile of enfortumab vedotin plus pembrolizumab in locally advanced or metastatic urothelial carcinoma: a multicenter Japanese cohort study

恩普替尼(enfortumab vedotin)联合帕博利珠单抗(pembrolizumab)在局部晚期或转移性尿路上皮癌中的安全性特征:一项多中心日本队列研究

2025-11-010
PRE
Prognostic impact of lung metastasis in patients treated with androgen receptor signaling inhibitors for castration-sensitive prostate cancer: data from the ULTRA-Japan Consortium

去势敏感型前列腺癌患者接受雄激素受体信号抑制剂治疗后肺转移的预后影响: 来自超日本财团的数据

2025-10-010
PRE
Predictors of early progressive disease and antitumor effects by metastatic site in renal cell carcinoma treated with ipilimumab plus nivolumab

肾细胞癌患者接受伊匹木单抗联合纳武利尤单抗治疗时,早期进展性疾病及按转移部位的抗肿瘤效果的预测因子

2025-09-050
PRE
Prognostic Impact of Initial Prostate-Specific Antigen in Metastatic Hormone-Sensitive Prostate Cancer Patients With Extensive Bone Metastases Under Androgen Receptor Signaling Inhibitor

广泛骨转移的转移性激素敏感型前列腺癌患者接受雄激素受体信号抑制剂治疗时,初始前列腺特异性抗原的预后影响

2025-07-270
PRE